Share-based Payment Arrangement, Expense of FibroBiologics, Inc. from 31 Dec 2022 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
FibroBiologics, Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2022 to 31 Dec 2025.
  • FibroBiologics, Inc. Share-based Payment Arrangement, Expense for the quarter ending 31 Dec 2025 was $702,000, a 19% increase year-over-year.
  • FibroBiologics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 31 Dec 2025 was $2,686,000, a 21% increase year-over-year.
  • FibroBiologics, Inc. annual Share-based Payment Arrangement, Expense for 2025 was $2,686,000, a 21% increase from 2024.
  • FibroBiologics, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $2,219,000, a 26% increase from 2023.
  • FibroBiologics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $1,765,000, a 566% increase from 2022.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

FibroBiologics, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $2,686,000 $702,000 +$114,000 +19% 01 Oct 2025 31 Dec 2025 10-K 24 Feb 2026 2025 FY
Q3 2025 $2,572,000 $704,000 +$132,000 +23% 01 Jul 2025 30 Sep 2025 10-Q 31 Oct 2025 2025 Q3
Q2 2025 $2,440,000 $729,000 +$150,000 +26% 01 Apr 2025 30 Jun 2025 10-Q 31 Jul 2025 2025 Q2
Q1 2025 $2,290,000 $551,000 +$71,000 +15% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 $2,219,000 $588,000 +$159,000 +37% 01 Oct 2024 31 Dec 2024 10-K 24 Feb 2026 2025 FY
Q3 2024 $2,060,000 $572,000 +$132,000 +30% 01 Jul 2024 30 Sep 2024 10-Q 31 Oct 2025 2025 Q3
Q2 2024 $1,928,000 $579,000 +$131,000 +29% 01 Apr 2024 30 Jun 2024 10-Q 31 Jul 2025 2025 Q2
Q1 2024 $1,797,000 $480,000 +$32,000 +7.1% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025 2025 Q1
Q4 2023 $1,765,000 $429,000 01 Oct 2023 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q3 2023 $440,000 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024 2024 Q3
Q2 2023 $448,000 01 Apr 2023 30 Jun 2023 10-Q 07 Aug 2024 2024 Q2
Q1 2023 $448,000 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024 2024 Q1

FibroBiologics, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $2,686,000 +$467,000 +21% 01 Jan 2025 31 Dec 2025 10-K 24 Feb 2026 2025 FY
2024 $2,219,000 +$454,000 +26% 01 Jan 2024 31 Dec 2024 10-K 24 Feb 2026 2025 FY
2023 $1,765,000 +$1,500,000 +566% 01 Jan 2023 31 Dec 2023 10-K 31 Mar 2025 2024 FY
2022 $265,000 01 Jan 2022 31 Dec 2022 10-K 29 Feb 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.